11/24/2015 - 1:31pm

Eli Lilly and Co.’s Petrazza in a trial extended the lives of patients who took the drug in combination with two forms of chemotherapy to 11.5 months. 

11/24/2015 - 1:12pm

In a Q3 that saw a 14% increase in sales, Fred’s reported earnings that show a marked improvement over the company’s performance last year. 

11/24/2015 - 11:18am

Mylan has introduced its generic of Jazz Pharmaceuticals’ schizophrenia treatment. 

11/24/2015 - 10:47am

Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)

11/23/2015 - 4:37pm

The popular Oreo Churros line introduced by J&J Snack Foods last November has two new creme-filled offerings. 

11/23/2015 - 4:10pm

The FDA has approved Bristol-Myers Squibb’s Opdivo as a treatment for renal cell carcinoma in some patients. 

11/23/2015 - 4:01pm

Earlier this year, California and Oregon passed laws allowing pharmacists to prescribe birth control to patients. As the measure is set to roll out in the first half of 2016, the New York Times has reported on the growing trend of states allowing pharmacists to prescribe contraceptives, noting its potential impact on medically underserved populations. “I feel strongly that this is what’s best for women’s health in the 21st century, and I also feel it will have repercussions for decreasing poverty because one of the key things for women in poverty is unintended pregnancy,” Oregon Rep. Knute Buehler, the Republican who sponsored Oregon’s law, told NYT. (New York Times)

11/23/2015 - 3:49pm

Greenstone received final approval from the Food and Drug Administration for its generic Zyvox. 

11/23/2015 - 3:26pm

CVS Health has opted to only offer one of the two new PCSK9 inhibitors on its CVS/caremark commercial formularies.